insights_auto
Outlook: 81.8% bullish·0.0% bearish
Go to analysischevron_right
ADPT:NASDAQ
Adaptive Biotechnologies Corp
$29.04
arrow_downward
-1.49%(-0.44) 1D
$29.04
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 8 analysts giving stock ratings to ADPT in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for ADPT in the last 3 months.
Highest
Current $29.04
$35.00 (+20.52%)
Average
$33.43 (+15.12%)
Lowest
$27.00 (-7.02%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
David Westenberg Piper Sandler | Buy | Reiterated | $35.00 | +20.5% | 11/10/2026 |
Subbu Nambi Guggenheim | Buy | Reiterated | $34.00 | +17.1% | 11/10/2026 |
Casey Woodring J.P. Morgan | Buy | Reiterated | $35.00 | +20.5% | 11/09/2026 |
Mark Massaro BTIG | Buy | Reiterated | $34.00 | +17.1% | 11/05/2026 |
Daniel Brennan TD Cowen | Buy | Reiterated | $34.00 | +17.1% | 11/05/2026 |
Kallum Titchmarsh Morgan Stanley | Hold | Maintained | $27.00 | -7% | 10/13/2026 |
Evie Koslosky Goldman Sachs | Buy | Initiated | $35.00 | +20.5% | 09/29/2026 |
William Bonello Craig-Hallum | Buy | Maintained | - | - | 09/17/2026 |
Sebastian Sandler J.P. Morgan | Buy | Maintained | $27.00 | -7% | 07/30/2026 |
Matt Larew William Blair | Buy | Maintained | - | - | 07/30/2026 |
Andrew Brackmann William Blair | Buy | Reiterated | - | - | 06/16/2026 |